Publication | Closed Access

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study

Picca StudyGastrointestinal OncologyMedicineCisplatin/gemcitabine ChemotherapyBiliary CancerPathologyCancer TreatmentOncologyRadiation OncologyCancer ResearchMolecular OncologyKras Wild-type Patients